COMPASS Pathways Plc - American Depository Shares (CMPS)

COMPASS Pathways is a biotechnology company dedicated to advancing mental health treatment through innovative therapies

It focuses on developing psilocybin therapy, a novel approach to addressing conditions such as treatment-resistant depression. By conducting clinical trials and research, the company seeks to create evidence-based solutions that harness the potential of psychedelic substances in a controlled and therapeutic context. COMPASS Pathways aims to improve patient outcomes and transform mental health care through its pioneering work in the field of psychedelics and mental health.